The previous Paralympic logo incorporated the Tae-Geuk, which is a traditional Korean decorative motif. According to oriental philosophy, Tae-Geuk refers to the ultimate reality from which all things ...

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life ...

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...

Pioneers like Alnylam Pharmaceuticals have led the RNA interference field for years. Now, a crop of young biotechs is ...

The global pharmaceutical industry is growing and offers an attractive opportunity for investors. Well-established pharmaceutical stocks include AbbVie, Eli Lilly, Johnson & Johnson, and Pfizer.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

A good imagination and persistence are required. Medicinal and pharmaceutical chemists apply their chemistry training to the process of synthesizing new pharmaceuticals. They also improve the ...

LTR Pharma Limited (AU:LTP) has released an update. LTR Pharma Limited has made significant strides with its innovative erectile dysfunction ...

Verona Pharma ( (VRNA)) has released its Q3 earnings. Here is a breakdown of the information Verona Pharma presented to its investors. Verona Pharma, a biopharmaceutical company focused on chronic ...

Shares of Longboard Pharmaceuticals Inc. are surging more than 51% Monday, boosted by H. Lundbeck’s $2.6 billion deal to acquire the California-based clinical-stage biopharmaceutical company.

Further information can be found at: www.tmepharma.com. TME Pharma® and the TME Pharma logo are registered trademarks.

An announcement from NRX Pharmaceuticals ( (NRXP)) is now available. Stephen Willard resigned abruptly as CEO of NRx Pharmaceuticals to lead a new biotech firm, with Dr. Jonathan Javitt taking ...